EWTX - Edgewise Therapeutics, Inc.
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $-0.43
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$20.00
LOW:
$20.00
MEDIAN:
$20.00
CONSENSUS:
$20.00
DOWNSIDE:
35.30%
Market Cap:
3.27B
Volume:
802,283
Avg Volume:
1,363,520
52 Week Range:
10.6-31.29
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.28
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
117
IPO Date:
2021-03-26
EPS (TTM):
-1.45
P/E Ratio:
-18.44
Revenue (TTM):
N/A
Total Assets:
486.82M
Total Debt:
4.74M
Cash & Equiv:
41.67M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-34.3%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.39 | $-0.40 | +2.5% | — | — | — |
| 2025-08-07 | $-0.34 | $-0.42 | +19.0% | — | — | — |
| 2025-05-08 | $-0.43 | $-0.45 | +4.4% | — | — | — |
| 2025-03-03 | $-0.42 | $-0.39 | -7.7% | — | — | — |
| 2024-11-07 | $-0.36 | $-0.37 | +2.7% | — | — | — |
| 2024-08-08 | $-0.34 | $-0.36 | +5.6% | — | — | — |
| 2024-05-09 | $-0.33 | $-0.39 | +15.4% | — | — | — |
| 2024-02-22 | $-0.47 | $-0.44 | -6.8% | $2.3M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (133.81M) | (100.16M) | (67.64M) | (42.81M) | (17.05M) | (9.49M) |
| EPS | -1.45 | -1.57 | -1.26 | -0.86 | -0.35 | -0.19 |
| Total Assets | 486.82M | 340.04M | 367.10M | 285.23M | 131.14M | 24.54M |
| Total Debt | 4.74M | 5.41M | 4.41M | 0 | 160.21M | 0 |
| Cash & Equivalents | 41.67M | 86.10M | 21.99M | 15.57M | 104.92M | 23.65M |
| Operating Cash Flow | (109.03M) | (91.95M) | (52.63M) | (33.51M) | (14.63M) | (9.17M) |
| Free Cash Flow | (110.34M) | (97.69M) | (58.18M) | (34.17M) | (14.84M) | (9.35M) |
| FCF per Share | -1.19 | -1.53 | -1.09 | -0.69 | -0.30 | -0.19 |
| Book Value | 459.22M | 318.83M | 346.72M | 274.38M | (33.42M) | (16.85M) |
| Cash & ST Investments | 470.17M | 318.39M | 351.95M | 280.79M | 129.09M | 23.65M |
| ROC Equity | -0.29 | -0.31 | -0.20 | -0.16 | N/A | N/A |